. Author manuscript; available in PMC: 2018 Jan 1.

Published in final edited form as: Int J Tuberc Lung Dis. 2017 Jan 1;21(1):23–31. doi: 10.5588/ijtld.16.0433

Table 2.

Program services to enable treatment adherence available to MDR-TB patients at the time of this study

Anti-tuberculosis medicines provided to patients at no cost

Medications to manage adverse events provided to patients at no cost (limited formulary)

TB diagnostic tests provided to patients at no cost

Fixed amount provided for transportation costs (funds provided retrospectively, based upon adherence to appointments)

Food basket incentives (limited availability)

Temporary housing located near PMDT treatment centers for patients from rural areas (limited availability)

44 PMDT treatment centers located throughout the country to provide comprehensive MDR-TB services

Patient education (non-standardized)

Patient support groups (located within some facilities)

Small monetary bonus provided to patients at month 6, 12, and 18 months, if fully adherent during each 6-month period

MDR-TB = multidrug-resistant tuberculosis; PMDT = programmatic management of drug-resistant tuberculosis.